English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/207706
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

The Role of Brassica Bioactives on Human Health: Are We Studying It the Right Way?

AuthorsQuirante-Moya, Sarai; García-Ibañez, Paula; Quirante-Moya, Francisco; Villaño, Débora ; Moreno, Diego A.
KeywordsBrassica
Clinical trials
Glucosinolates
Issue Date2020
PublisherMultidisciplinary Digital Publishing Institute
CitationMolecules 25(7): 1591 (2020)
AbstractBrassica vegetables and their components, the glucosinolates, have been suggested as good candidates as dietary coadjutants to improve health in non-communicable diseases (NCDs). Different preclinical and clinical studies have been performed in the last decade; however, some concerns have been posed on the lack of established and standardized protocols. The different concentration of bioactive compounds used, time of intervention or sample size, and the lack of blinding are some factors that may influence the studies’ outcomes. This review aims to analyze the critical points of the studies performed with Brassica-related biomolecules and propose some bases for future trials in order to avoid biases.
Description© 2020 by the authors.
Publisher version (URL)https://doi.org/10.3390/molecules25071591
URIhttp://hdl.handle.net/10261/207706
DOI10.3390/molecules25071591
E-ISSN1420-3049
Appears in Collections:(CEBAS) Artículos
Files in This Item:
File Description SizeFormat 
Role_Quirante_Art2020.pdf468,33 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.